Упрощенная HTML-версия
172
phosphatidylethanolamine / J.J. Killion [et al.] // Cancer Biother. Radiopharm. –
1996. – Vol. 11, № 6. – P. 363-371.
271. Malpas J.S.
272. Measuring mucosal damage induced by cytotoxic therapy / N.M. Blijlevens
[et al.] // Support Care Cancer. – 2004. – Vol. 12, № 4. – P. 227-233.
273. Mesna ameliorates intestinal mucosa damage after ifosfamide
administration in the rabbit at a dose-related manner / P. Ypsilantis [et al.] // J. Surg.
Res. – 2004. – Vol. 121, № 1. – P. 84-91.
274. Modulation of molecular marker expression by induction chemotherapy in locally
advanced breast cancer: correlation with the response to therapy and the expression of MDRI
and LRP / J. Schneider [et al.] // Anticancer Res. -2000. -Vol. 20, №6. -P. 4373-4377.
275. Monoclonal antibodies to a zinc-binding protein of rat Paneth cells / M.
Sawada [et al.] // J. Histochem. Cytochem. – 1994; 42, № 4. – P. 467-472.
276. Moore J.V. The «gastrointestinal syndrome» after chemotherapy:
inferences from mouse survival time, and from histologically- and clonogenically-
defined cell death in intestinal crypts / J.V. Moore // Br.J. Cancer Suppl. – 1986. –
Vol. 7. – P. 16-19.
277. Mor F. IL-2 rescues antigen-specific T cells from radiation or
dexamethasone-induced apoptosis. Correlation with induction of Bcl-2 / F. Mor, I.R.
Cohen // J. Immunol. – 1996. – Vol. 156, № 2. – P. 515-522.
278. Morales A. Effects of inhibition of steroid biosynthesis on the lymphoid
system / A. Morales, A. W. Bruce // Invest. Urol. – 1974. – Vol. 12, № 1. – P. 54-56.
D. Longo [et al.] // Dev. Biol. –
2004. – Vol. 271, № 1. – P. 210-222.
280. Myung J. The ubiquitin-proteasome pathway and proteasome inhibitors / J.
Myung, K.B. Kim, C.M. Crews // Med. Res. Rev. – 2001. – Vol. 21, № 4. – P. 245-273.
281. Neutropenic enterocolitis in adults with acute leukemia / Y. Uzuka [et al.]
// Rinsho Ketsueki. – 1989. – Vol. 30, № 7. – P. 980-987.